International Pharmaceutical Industry, Vol 5. Issue 4 (Winter 2013)
Applying adaptive licensing strategies can significantly increase the value of R&D projects. Although regulatory frameworks do not include adaptive pathways yet, some strategies already work within the existing regulations and regulators encourage pilot schemes. Thus, a new opportunity to optimise R&D portfolio value has arisen.